WASHINGTON, July 23 -- Sen. Mike Braun, R-Ind., introduced the "Promising Pathway Act 2.0" on May 23, 2024. The text of the bill was released on July 19. S. 4426. A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes; to the Committee on Health, Education, Labor, and Pensions. The bill is cosponsored by Sens. Kirsten Gillibrand, D-N.Y., more ST